계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
ARYx Therapeutics
company
About
ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $55M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1997
- Number Of Employee
- 51 - 100
- Operating Status
- Close
ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$85.40M
ARYx Therapeutics has raised a total of
$85.40M
in funding over 2 rounds. Their latest funding was raised on
Feb 10, 2006 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 10, 2006 | Series E | $30.40M | 1 | — | — | Detail |
| Jun 1, 2004 | Series D | $55M | 3 |
Phase4 Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
ARYx Therapeutics is funded by 3 investors.
Phase4 Ventures
and Novel Bioventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Phase4 Ventures
|
— | Series E |
|
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
